VERTEX PHARMACEUTICALS INCORPORATED - , US SHAHLA JAMZAD - BELMONT MA, US MAJED FAWAZ - FOXBORO MA, US LAURA DAS - CHARLESTOWN MA, US CHONG-HUI GU - WABAN MA, US PATRICIA NELL HURTER - HARVARD MA, US MEGHNA JAI ISRANI - BOSTON MA, US MEGHAN M. JOHNSTON - WAKEFIELD MA, US DRAGUTIN KNEZIC - WATERTOWN MA, US ANDREW G. KUZMISSION - SHREWSBURY MA, US HONGREN WANG - LEXINGTON MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - CAMBRIDGE MA
International Classification:
A61K 31/47
US Classification:
424464, 514312
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N—[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
Pharmaceutical Composition And Administrations Thereof
- Boston MA, US Shahla JAMZAD - Belmont MA, US Majed FAWAZ - Foxboro MA, US Laura DAS - Charlestown MA, US Chong-Hui GU - Waban MA, US Patricia Nell HURTER - Harvard MA, US Meghna Jai ISRANI - Boston MA, US Meghan M. JOHNSTON - Wakefield MA, US Dragutin KNEZIC - Watertown MA, US Andrew G. KUZMISSION - Shrewsbury MA, US HongRen WANG - Lexington MA, US
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
Pharmaceutical Composition And Administrations Thereof
- Boston MA, US Shahla JAMZAD - Belmont MA, US Majed FAWAZ - Foxboro MA, US Laura DAS - Charlestown MA, US Chong-Hui GU - Waban MA, US Patricia Nell HURTER - Harvard MA, US Meghna Jai ISRANI - Boston MA, US Meghan M. JOHNSTON - Wakefield MA, US Dragutin KNEZIC - Watertown MA, US Andrew G. KUZMISSION - Shrewsbury MA, US HongRen WANG - Lexington MA, US
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
Pharmaceutical Composition And Administrations Thereof
- Boston MA, US Shahla JAMZAD - Belmont MA, US Majed FAWAZ - Foxboro MA, US Laura DAS - Charlestown MA, US Chong-Hui GU - Waban MA, US Patricia Nell HURTER - Harvard MA, US Meghna Jai ISRANI - Boston MA, US Meghan M. JOHNSTON - Wakefield MA, US Dragutin KNEZIC - Watertown MA, US Andrew G. KUZMISSION - Shrewsburg MA, US HongRen WANG - Lexington MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Boston MA
International Classification:
A61K 9/20 A61K 31/47
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
Pharmaceutical Composition And Administrations Thereof
- Boston MA, US Shahla Jamzad - Belmont MA, US Majed Fawaz - Foxboro MA, US Laura Das - Charlestown MA, US Chong-Hui Gu - Waban MA, US Patricia Nell Hurter - Harvard MA, US Meghan M. Johnston - Wakefield MA, US Dragutin Knezic - Watertown MA, US Andrew G. Kuzmission - Shrewsburg MA, US HongRen Wang - Lexington MA, US
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
Pharmaceutical Composition And Administrations Thereof
- Boston MA, US Shahla Jamzad - Belmont MA, US Majed Fawaz - Foxboro MA, US Laura Das - Charlestown MA, US Chong-Hui Gu - Waban MA, US Patricia Nell Hurter - Harvard MA, US Meghna Jai Israni - Boston MA, US Meghan M. Johnston - Wakefield MA, US Dragutin Knezic - Watertown MA, US Andrew G. Kuzmission - Shrewsburg MA, US HongRen Wang - Lexington MA, US
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
Pharmaceutical Composition And Administrations Thereof
- Boston MA, US Shahla Jamzad - Belmont MA, US Majed Fawaz - Foxboro MA, US Laura Das - Charlestown MA, US Chong-Hui Gu - Waban MA, US Patricia Nell Hurter - Harvard MA, US Meghna Jai Israni - Boston MA, US Meghan M. Johnston - Wakefield MA, US Dragutin Knezic - Watertown MA, US Andrew G. Kuzmission - Shrewsburg MA, US HongRen Wang - Lexington MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Boston MA
International Classification:
C07D 215/56 A61K 9/20 A61K 9/16
US Classification:
424464, 514312
Abstract:
The present invention relates to pharmaceutical compositions containing a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide including formulations of the solid dispersions into powders, granules and mini-tablets, methods for manufacturing and processing the powders, granules and mini-tablets, and methods for treating cystic fibrosis employing the pharmaceutical composition.
CSpire - Starkville, Mississippi Oct 2006 - Dec 2012
Account Service Representative II
CSpire - Starkville, Mississippi Jun 2006 - Oct 2006
Customer Flow Coordinator
Starkville Country Club - Starkville, Mississippi Sep 2005 - Oct 2006
Waitress
Education:
Mississippi State University 2002 - 2004
Keesler Air Force Base Community College 2002 - 2003
Biloxi High School 1999 - 2002
Graduated